series-c-plus
Stage
1
Investors
About
Welcome to KGbio - Clinical-stage biotech company Backed by Kalbe and Genexine and US private equity giant General Atlantic. Licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas and also contract manufacturing.
Explore KGBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.